Seasonal affective disorder

Current Opinion in Psychiatry

Volumn 12, Issue 1, 1999, Pages 81-86

  Zulman, Donna M ^a   Oren, Dan A ^a,b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; MELATONIN; SEROTONIN;

AFFECTIVE NEUROSIS; AIR; CIRCADIAN RHYTHM; DEPRESSION; GENETIC ASSOCIATION; HUMAN; PATHOPHYSIOLOGY; PERSONALITY; PHOTOTHERAPY; REVIEW; SEROTONINERGIC SYSTEM; SLEEP DEPRIVATION; WINTER;

EID: 0033030871     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-199901000-00022     Document Type: Review

References (51)

1. Rosenthal NE, Sack DA, Gillin JC, Lewy AL, Goodwin FK, Davenport Y. Seasonal affective disorder: a description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry 1984; 41:72-80
2. Young MA, Meaden PM, Fogg LF, Cherin EA, Eastman CI. Which environmental variables are related to the onset of seasonal affective disorder? J Abnorm Psychol 1997; 106:554-562. Two studies were completed to examine photoperiod variations in onset risk of SAD. The first demonstrated that the risk of developing SAD in five locations is a function of photoperiod. The second focused on one location for 7 years, and found no evidence that daily hours of sunshine, temperature or radiation affects onset risk
3. Hansen V, Lund E, Smith-Sivertsen T. Self-reported mental distress under the shifting daylight in the high north. Psychol Med 1998; 28:447-452. A questionnaire completed by 60.8% of a small Norwegian community suggested a higher prevalence of winter depression at high latitudes. A problem in the dark period was reported by 27%, and 11.1% of women and 4.8% of men reported depression in the winter
4. Dam H, Jakobsen K, Mellerup E. Prevalence of winter depression in Denmark. Acta Psychiatr Scand 1998; 97:1-4. This study of 1794 subjects in Copenhagen found 12% of the respondents had a Global Seasonality Score indicative of SAD, with women and younger people most sensitive to seasonal and weather changes
5. Murray GW, Hay DA. Seasonal affective disorder in Australia: is photoperiod critical? Aust NZ J Psychiatry 1997; 31:279-284. The results of this study of 526 women residing across the latitudes of Australia suggest that predisposition to SAD/seasonality may not be photoperiod specific in that country
6. Jang KL, Lam RW, Livesley WJ, Vernon PA. The relationship between seasonal mood change and personality: more apparent than real? Acta Psychiatr Scand 1997; 95:539-543. This study of the relationship between personality and seasonality confirmed previous reports regarding different hemispheres, measures of personality, and clinical and general population samples, but determined that personality accounts for under 15% of the total variance
7. Jang KL, Lam RW, Harris JA, Vernon PA, Livesley WJ. Seasonal mood change and personality: an investigation of genetic co-morbidity. Psychiatry Res 1998; 78:1-7. This twin study found strong correlations between seasonality and personality and attributed the correlations to shared genetic influences. Personality factors with high correlations with seasonality included neuroticism, cognitive dysregulation, affective lability, araiousness, and stimulus seeking
8. Levitan RD, Rector NA, Bagby RM. Negative attributional style in seasonal and nonseasonal depression. Am J Psychiatry 1998; 155:428-430. Using the results from Attributional Style Questionnaires completed by patients with seasonal and nonseasonal depression, this study determined that dysfunctional cognitions do not play a significant role in SAD
9. Terman M, Terman JS, Ross DC. A controlled trial of timed bright light and negative air ionization for treatment of seasonal affective disorder. Arch Gen Psychiatry (in press)
10. Sonis WA, Yellin AM, Garfinkel BD, Hoberman HH. The antidepressant effect of light in seasonal affective disorder of childhood and adolescence. Psychopharmacol Bull 1987; 23:360-363
11. Swedo SE, Allen AJ, Glod CA, Clark CH, Teicher MH, Richter D, et al. A controlled trial of light therapy for the treatment of pediatric seasonal affective disorder. J Am Acad Child Adolesc Psychiatry 1997; 36:816-821. In this study, 28 children received active light therapy, and parents' (but not childrens') responses to the SIGH-SAD demonstrated significantly lower depression scores during treatment. Unfortunately, the study failed to present effect sizes or confidence intervals, therefore limiting the clinical usefulness of the results
12. Magnusson A. Light therapy to treat winter depression in adolescents in Iceland. J Psychiatry Neurosci 1998; 23:118-122. The outcome of light therapy for 18 college students showed improved concentration, but no improvement in school attendance
13. Graw P. Gisin B, Wirz-Justice A. Follow-up study of seasonal affective disorder in Switzerland, Psychopathology 1997; 30:208-214. In a follow-up of 39 SAD patients 2-5 years after light therapy, 10 patients continued to have recurrent major depressive episodes in the winter, 17 manifested subsyndromal SAD (two of whom had recurrent brief seasonal depression), eight had recovered, and four had shifted in symptomatology
14. Lee TMC, Chan CCH, Paterson JG, Janzen HL, Blashko CA. Spectral properties of phototherapy for seasonal affective disorder: a meta-analysis. Acta Psychiatr Scand 1997; 96:117-121. This meta-analytic study of the antidepressant effects of different spectral properties of light on SAD concluded that ultraviolet waves are not essential for symptom alleviation, and short to medium wavelengths (blue/green/yellow) are most effective in therapy
15. Lam RW, Buchanan A, Clark CM, Remick RA. Ultraviolet versus non- ultraviolet light therapy for seasonal affective disorder. J Clin Psychiatry 1991; 52:213-216
16. Oren DA, Brainard GC, Johnston SH, Joseph-Vanderpool JR, Sorek E, Rosenthal NE. Treatment of seasonal affective disorder with green light and red light. Am J Psychiatry 1991; 148:509-511
17. Kogan AO, Guilford PM. Side effects of short-term 10,000-lux light therapy. Am J Psychiatry 1998; 155:293-294. Of 70 subjects treated with 10 000-lux light, 45.7% experienced side effects, most commonly headaches and eye or vision problems occurring early in treatment
18. Terman M, Schlager D, Fairhurst S, Perlman B. Dawn and dusk simulation as a therapeutic intervention, Biol Psychiatry 1989; 25:966-970
19. Meesters Y, Case study: dawn simulation as maintenance treatment in a nine- year-old patient with seasonal affective disorder. J Am Acad Child Adolesc Psychiatry (in press)
20. Avery DH, Bolte MA, Ries R. Dawn simulation treatment of abstinent alcoholics with winter depression. J Clin Psychiatry 1998; 59:36-42. In a study of dawn simulation, white dawn treatment decreased depression severity in abstinent alcoholic individuals by approximately 50%, whereas red dawn treatment had little effect
21. Kripke DF. Photoperiodic mechanisms for depression and its treatment. In: Biological psychiatry. Perris C, Struwe G, Jansson B (editors). Elsevier-North Holland Biomedical Press; 1981. pp. 1249-1252
22. Kripke DF, Risch SF, Janowsky DS. Bright white light alleviates depression. Psychiatry Res 1983; 10:105-112
23. Kripke DF. Light treatment for nonseasonal depression: speed, efficacy, and combined treatment. J Affect Disord 1998; 49:109-117. The results of this comparison of light treatment for nonseasonal major depression and winter depression suggest that bright light may be combined with standard therapy for treating nonseasonal depression.
24. Jang KL, Lam RW, Livesley WJ, Vernon PA. Gender differences in the heritability of seasonal mood change. Psychiatry Res 1997; 70:145-154. Sex differences in genetic and environmental influence of seasonal mood change were determined using the Seasonal Pattern Assessment Questionnaire. Although symptoms like sleep patterns, mood, appetite, and energy levels were accounted for primarily by additive genetic effects, weight changes were not heritable
25. Rosenthal NE, Mazzanti CM, Barnett RL, Hardin TA, Turner EH, Lam GK, et al. Role of serotonin transporter promoter repeat length polymorphism (5-HTTLPR) in seasonally and seasonal affective disorder. Mol Psychiatry 1998; 3:175-177. SAD patients were genotyped for the serotonin-transporter-linked polymorphism (5-HTTLPR), which has been associated with neuroticism and depression. Patients with SAD were less likely to have both long (l) alleles and more likely to have the short (s) allele, and SAD patients with the l/l genotype had a lower mean seasonality score than SAD patients with other genotypes. These results are further evidence for a relationship between behavior and a genetic variation in the serotonin transporter
26. Szádóczky E, Falus A, Németh A, Teszéri G, Moussong-Kovács E. Effect of phototherapy on 3H-imipramine binding sites in patients with SAD, non-SAD and in healthy controls. J Affect Disord 1991; 22:179-184
27. Jacobsen FM, Mueller EA, Rosenthal NE, Rogers S, Hill JS, Murphy DL. Behavioral responses to intravenous meta-chlorophenylpiperazine in patients with seasonal affective disorder and control subjects before and after phototherapy. Psychiatry Res 1994; 52:181-197
28. Lam RW, Zis AP, Grewal A, Delgado PL, Charney DS, Krystal JH. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Arch Gen Psychiatry 1996; 1996:41-44
29. Levitan RD, Kaplan AS, Brown GM, Vaccarino FJ, Kennedy SH, Levitt AJ, Joffe RT. Hormonal and subjective responses to intravenous m-chlorophenylpiperazine in women with seasonal affective disorder. Arch Gen Psych 1998; 55:244-249. The response of unmedicated female SAD patients to m-CPP during the follicular phase of the menstrual cycle showed blunted prolactin and less sadness than control individuals. These results are further evidence of dysfunction at or downstream to central serotonergic receptors in patients with SAD
30. Schwartz PJ, Murphy DL, Wehr TA, Garcia-Borreguero D, Oren DA, Moul DE, et al. Effects of meta-chlorophenylpiperazine infusions in patients with seasonal affective disorder and healthy control subjects. Diurnal responses and nocturnal regulatory mechanisms. Arch Gen Psychiatry 1997; 54:375-385. When m-CPP was administered to 17 depressed patients with SAD and 15 control individuals, significant increases in 'activation-euphoria' ratings resulted only in depressed patients. m-CPP also produced blunted corticotropin and norepinephrine responses. Light treatment reduced nocturnal core temperatures in both patients and control individuals, and reduced baseline depression ratings and mean growth hormone concentrations in patients with SAD
31. Palchikov VE, Zolotarev DY, Danilenko KV, Putilov AA. Effects of the seasons and of bright light administered at different times of day on sleep EEG and mood in patients with seasonal affective disorder. Biol Rhythm Res 1997; 28:166- 184. An examination of REM and non-REM sleep in female patients with winter depression before and after light treatment determined that hypersomnia, a possible trait marker for winter depression, may be caused by the abnormally high need for REM sleep
32. 3H]paroxetine
33. 2+ response, and 5-HT content in winter seasonal affective disorder. Biol Psychiatry 1994; 36:458-466
34. Yatham LN, Lam RW, Zis AP. Growth hormone response to sumatriptan (5- HT1D agonist) challenge in seasonal affective disorder: effects of light therapy. Biol Psychiatry 1997; 42:24-29. The results of this study with 11 SAD patients and nine healthy control individuals provide support for the role of serotonergic system in SAD. When SAD patients were challenged with a novel serotonin-1D receptor agonist sumatriptan during winter depression, growth hormone responses were significantly inhibited, and normalized after light treatment.
35. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger G. Serotonin function and the mechanism of antidepressant action. Arch Gen Psychiatry 1990; 47:411-418
36. Neumeister A, Praschak-Rieder N, Hesselmann B, Rao M, Gluck J, Kasper S. Effects of tryptophan depletion on drug-free patients with seasonal affective disorder during a stable response to bright light therapy. Arch Gen Psychiatry 1997; 54:133-138. Short-term tryptophan depletion in SAD patients who had been in remission for at least 2 weeks induced a transient depressive relapse. This suggests that maintenance of light-therapy induced remission may depend on a functional serotonin system, and this system may be involved in the mechanism of action of light therapy
37. Neumeister A, Turner EH, Matthews JR, Postolache TT, Barnett RL, Rauh M, et al. Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Arch Gen Psychiatry 1998; 55:524-530. This study showed that when SAD patients who had responded to daily light therapy were depleted of either tryptophan or catecholamine, there was an increase in depressive symptoms as measured by the Hamilton Depression Rating Scale (SAD version). This study adds further to understanding that winter depression may involve multiple neurotransmitter systems
38. Salomon RM, Miller HL, Delgado PL, Charney D. The use of tryptophan depletion to evaluate central serotonin function in depression and other neuropsychiatric disorders. Int Clin Psychopharmacol 1993; 8 (Suppl 2):41- 46
39. Kräuchi K, Keller U, Leonhardt G, Brunner DP, van der Velde P, Haug H-J, Wirz-Justice A. Accelerated post-glucose glycaemia and altered alliesthesia-test in Seasonal affective disorder. J Affect Disord (in press). In an investigation of the link between mood, food and metabolic function in SAD, SAD patients exhibited faster postglucose glycemic and insulin responses, and increased hedonic ratings of high concentrated sucrose solutions when depressed in the winter than after 1 week of light treatment or in the summer
40. Avery DH, Dahl K, Savage MV, Brengelmann GL, Larson LH, Kenny MA, et al. Circadian temperature and Cortisol rhythms during a constant routine are phase- delayed in hypersomnic winter depression. Biol Psychiatry 1997; 41:1109- 1123. Data from this study of six female SAD patients and six control individuals suggests that circadian and cortisol rhythms are phase-delayed relative to sleep, whereas the thyroid-stimulating hormone rhythm remains constant. Assessments made after morning bright light therapy displayed phase-advances in circadian and cortisol rhythms
41. Lewy AJ, Sack RL, Singer CM, White DM. The phase shift hypothesis for bright light's therapeutic mechanism of action: theoretical considerations and experimental evidence. Psychopharmacol Bull 1987; 23:349-353
42. Vasile RG, Sachs G, Anderson JL, Lafer B, Matthews E, Hill T. Changes in regional cerebral blood flow following light treatment for seasonal affective disorder: responders versus nonresponders. Biol Psychiatry 1997; 42:1000-1005. In this study, SAD patients underwent functional brain imaging studies before and after light treatment. Patients who responded to treatment showed relative increases in regional cerebral blood flow in all brain regions compared with cerebellum, whereas nonresponders showed no change or decreases in regional cerebral blood flow relative to cerebellum
43. Lee TM, Blashko CA, Janzen HL, Paternson JG, Chan CC. Pathophysiological mechanism of seasonal affective disorder. J Affect Disord 1997; 46:25-38
44. Campbell SC, Murphy PJ. Extraocular circadian phototransduction in humans. Science 1998; 279:396-399. The results of this study show a systematic relation between light pulses presented to the popliteal region and the magnitude and direction of phase shifts in body temperature and melatonin concentrations. These results demonstrate that humans may be capable of extraretinal circadian phototransduction, suggesting possible new forms of treatment for sleep and circadian rhythm disorders
45. Oren DA, Terman M. Tweaking the human circadian clock with light. Science 1998; 279:396-399. This article presents a possible pathway by which a light signal presented to the popliteal region may be carried to the endogenous clock. The model postulates that humoral phototransduction, in which heme moieties serve as photoreceptors, may mediate light's chronobiologic effects
46. Oren DA. Humoral phototransduction; blood is a messenger. Neuroscientist 1996; 2:207-210
47. Oren DA, Moul DE, Schwartz PJ, Alexander JR, Yamada EM, Rosenthal NE. An investigation of opthalmic function in winter seasonal affective disorder. Depression 1993; 1:29-37
48. Kasper S. Treatment of seasonal affective disorders (SAD) with hypericum extract. Pharmacopsychiatry 1997; 30 (Suppl 2):89-93
49. Partonen T, Vakkuri O, Lönnqvist J. Suppression of melatonin secretion by bright light in seasonal affective disorder. Biol Psychiatry 1997; 42:509-513. Melatonin concentration and subjective sleepiness in SAD patients and control individuals were measured after exposure to 3300-lux light for 5 min and 1 h, respectively. Although there was no significant difference in suppression of melatonin, exposure to light reduced the level of subjective sleepiness more among patients than control individuals
50. Lewy AJ, Bauer VK, Cutler NL, Sack RL. Melatonin treatment of winter depression: a pilot study. Psychiatry Res 1998; 77:57-61. In a small sample of five patients with winter depression, melatonin treatment administered in the afternoon demonstrated significantly decreased depression ratings compared with placebo. These findings lend further support to the 'phase shift' hypothesis
51. Graw P, Haug H-J, Leonhardt G, Wirz-Justice A. Sleep deprivation response in seasonal affective disorder during a 40-h constant routine. J Affect Disord 1998;48:69-74. This study demonstrates that the positive effect of sleep deprivation on patients with SAD is comparable to that of patients with nonseasonal major depression. Of 11 female SAD patients, 52% showed improvement of mood (compared with 29% of the eight control individuals)